![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » RPS Diagnostics Gains Updated CE Mark for RPC Test
RPS Diagnostics Gains Updated CE Mark for RPC Test
![ClearanceStamp_Blue.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Blue.gif?t=1576043968&width=430)
October 31, 2018
RPS Diagnostics’ FebriDx, a rapid point-of-care test, has received an updated CE Mark, clearing it for launch in the EU.
The diagnostic test allows for a 10-minute assessment of the patient’s immune response to an acute respiratory infection by analyzing a fingerstick blood sample.
The single-use device points out underlying, clinically significant infections in patients and determines if they are bacterial or viral.
Upcoming Events
-
21Oct